Researchers warn against use of transfusions for trial eligibility

10/21/2010 | MedPage Today (free registration)

Canadian researchers have reported three cases involving patients who underwent blood transfusions in order to qualify as participants for trials of new cancer drugs. The researchers have expressed concern over the practice, citing the risks associated with transfusions, and are recommending that all other options -- such as using anemia treatments -- be exhausted first before resorting to blood transfusions.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL